Skip to main content
Erschienen in: Forensic Science, Medicine and Pathology 2/2013

01.06.2013 | Case Report

Lethal neuroleptic malignant syndrome due to amisulpride

verfasst von: Frank Musshoff, Elke Doberentz, Burkhard Madea

Erschienen in: Forensic Science, Medicine and Pathology | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

A 42-year old-man was found lying in his bed having seizures. Later he became unconscious and hypotonic developing mydriasis as well as rigidity. The body core temperature (rectal temperature) was above 42 °C. Blood pH was decreased during treatment, and his general condition deteriorated. The patient developed gasping respiration, ventricular fibrillation, and died. During autopsy and histological investigation cerebral and pulmonary edema were noted together with general congestion of the internal organs. Further observations included contraction bands of myocytes, a contracted spleen, fibrosis of the liver, and gall stones. Toxicological analyses of peripheral blood revealed the following results: amisulpride 4.65 mg/l, biperiden 0.12 mg/l, imipramine 0.33 mg/l, and desipramine 0.68 mg/l. An amisulpride-induced neuroleptic malignant syndrome was therefore diagnosed as the patho-physiological mechanism leading to death.
Literatur
1.
Zurück zum Zitat Trollor JN, Chen X, Sachdev PS. Neuroleptic malignant syndrome associated with atypical antipsychotic drugs. CNS Drugs. 2009;23:477–92.PubMedCrossRef Trollor JN, Chen X, Sachdev PS. Neuroleptic malignant syndrome associated with atypical antipsychotic drugs. CNS Drugs. 2009;23:477–92.PubMedCrossRef
2.
Zurück zum Zitat Guzofski S, Peralta R. Neuroleptic malignant syndrome, with attention to its occurrence with atypical antipsychotic medication: a review. Jeff J Psych. 2006;20(1):54–61. Guzofski S, Peralta R. Neuroleptic malignant syndrome, with attention to its occurrence with atypical antipsychotic medication: a review. Jeff J Psych. 2006;20(1):54–61.
3.
Zurück zum Zitat Addonizio G, Susman VL, Roth SD. Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients. Am J Psychiatry. 1986;143:1587–90.PubMed Addonizio G, Susman VL, Roth SD. Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients. Am J Psychiatry. 1986;143:1587–90.PubMed
4.
Zurück zum Zitat American Psychiatric Association. Diagnostic and statistical manual. 4th ed. (text revision). Arlington, VA: American Psychiatric Publishing; 2000. American Psychiatric Association. Diagnostic and statistical manual. 4th ed. (text revision). Arlington, VA: American Psychiatric Publishing; 2000.
5.
Zurück zum Zitat Levenson JL. Neuroleptic malignant syndrome. Am J Psychiatry. 1985;142:1137–45.PubMed Levenson JL. Neuroleptic malignant syndrome. Am J Psychiatry. 1985;142:1137–45.PubMed
6.
Zurück zum Zitat Musshoff F, Kröner L, Padosch SA, Madea B. Fatal intoxication with amisulpride and presentation of organ distribution. Arch Kriminol. 2005;215:158–63.PubMed Musshoff F, Kröner L, Padosch SA, Madea B. Fatal intoxication with amisulpride and presentation of organ distribution. Arch Kriminol. 2005;215:158–63.PubMed
7.
Zurück zum Zitat Schulz M, Iwersen-Bergmann S, Andresen H, Schmoldt A. Therapeutic and toxic blood concentrations of nearly 1000 drugs and other xenobiotics. Crit Care. 2012;16(4):R136.PubMedCrossRef Schulz M, Iwersen-Bergmann S, Andresen H, Schmoldt A. Therapeutic and toxic blood concentrations of nearly 1000 drugs and other xenobiotics. Crit Care. 2012;16(4):R136.PubMedCrossRef
8.
Zurück zum Zitat Tracqui A, Mutter-Schmidt C, Kintz P, Berton C, Mangin P. Amisulpride poisoning: a report on two cases. Hum Exp Toxicol. 1995;14:294–8.PubMedCrossRef Tracqui A, Mutter-Schmidt C, Kintz P, Berton C, Mangin P. Amisulpride poisoning: a report on two cases. Hum Exp Toxicol. 1995;14:294–8.PubMedCrossRef
9.
Zurück zum Zitat Isbister GK, Murray L, John S, Hackett LP, Haider T, O’Mullane P, Gosselin S, Daly F. Amisulpride deliberate self-poisoning causing severe cardiac toxicity including QT prolongation and torsades de pointes. Med J Aust. 2006;184:354–6.PubMed Isbister GK, Murray L, John S, Hackett LP, Haider T, O’Mullane P, Gosselin S, Daly F. Amisulpride deliberate self-poisoning causing severe cardiac toxicity including QT prolongation and torsades de pointes. Med J Aust. 2006;184:354–6.PubMed
10.
Zurück zum Zitat Lynch MJ, Woods J, George N, Gerostamoulos D. Fatality due to amisulpride toxicity: a case report. Med Sci Law. 2008;48:173–7.PubMedCrossRef Lynch MJ, Woods J, George N, Gerostamoulos D. Fatality due to amisulpride toxicity: a case report. Med Sci Law. 2008;48:173–7.PubMedCrossRef
11.
Zurück zum Zitat Curran MP, Perry CM. Amisulpride: a review of its use in the management of schizophrenia. Drugs. 2001;61:2123–50.PubMedCrossRef Curran MP, Perry CM. Amisulpride: a review of its use in the management of schizophrenia. Drugs. 2001;61:2123–50.PubMedCrossRef
12.
Zurück zum Zitat Rosenzweig P, Canal M, Patat A, Bergougnan L, Zieleniuk I, Bianchetti G. A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers. Hum Psychopharmacol. 2002;17:1–13.PubMedCrossRef Rosenzweig P, Canal M, Patat A, Bergougnan L, Zieleniuk I, Bianchetti G. A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers. Hum Psychopharmacol. 2002;17:1–13.PubMedCrossRef
13.
Zurück zum Zitat Dorne R, Pommier C, Manchon M, Berny C. Intoxication with amisulpride (Solian): a case with toxicologic documentations. Therapie. 2000;55:325–8.PubMed Dorne R, Pommier C, Manchon M, Berny C. Intoxication with amisulpride (Solian): a case with toxicologic documentations. Therapie. 2000;55:325–8.PubMed
14.
Zurück zum Zitat Bottlender R, Jager M, Hofschuster E, Dobmeier P, Moller HJ. Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient. Pharmacopsychiatry. 2002;35:119–21.PubMedCrossRef Bottlender R, Jager M, Hofschuster E, Dobmeier P, Moller HJ. Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient. Pharmacopsychiatry. 2002;35:119–21.PubMedCrossRef
15.
Zurück zum Zitat Atbasoglu EC, Ozguven HD, Can Saka M, Goker C. Rhabdomyolysis and coma associated with amisulpride: a probable atypical presentation of neuroleptic malignant syndrome. J Clin Psychiatry. 2004;65(12):1724–5.PubMedCrossRef Atbasoglu EC, Ozguven HD, Can Saka M, Goker C. Rhabdomyolysis and coma associated with amisulpride: a probable atypical presentation of neuroleptic malignant syndrome. J Clin Psychiatry. 2004;65(12):1724–5.PubMedCrossRef
16.
Zurück zum Zitat Abay E, Kose R. Amisulpride-induced neuroleptic malignant syndrome. J Neuropsychiatry Clin Neurosci. 2007;19:488–9.PubMedCrossRef Abay E, Kose R. Amisulpride-induced neuroleptic malignant syndrome. J Neuropsychiatry Clin Neurosci. 2007;19:488–9.PubMedCrossRef
17.
Zurück zum Zitat Harter C, Obier C, Druschky KF, Eikelmann B. Malignant neuroleptic syndrome associated with amisulpride. Nervenarzt. 2008;79:86–9.PubMedCrossRef Harter C, Obier C, Druschky KF, Eikelmann B. Malignant neuroleptic syndrome associated with amisulpride. Nervenarzt. 2008;79:86–9.PubMedCrossRef
18.
Zurück zum Zitat Peritogiannis V, Tsouli S, Pappas D, Mavreas V, Konitsiotis S. Neuroleptic malignant syndrome due to amisulpride in a patient with solvent-induced chronic toxic encephalopathy. Clin Neuropharmacol. 2007;30:245–6.PubMed Peritogiannis V, Tsouli S, Pappas D, Mavreas V, Konitsiotis S. Neuroleptic malignant syndrome due to amisulpride in a patient with solvent-induced chronic toxic encephalopathy. Clin Neuropharmacol. 2007;30:245–6.PubMed
19.
Zurück zum Zitat Tu MC, Hsiao CC. Amisulpride and neuroleptic malignant syndrome. Chang Gung Med J. 2011;34:536–40.PubMed Tu MC, Hsiao CC. Amisulpride and neuroleptic malignant syndrome. Chang Gung Med J. 2011;34:536–40.PubMed
20.
Zurück zum Zitat Pope HG Jr, Keck PE Jr, McElroy SL. Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. Am J Psychiatry. 1986;143:1227–33.PubMed Pope HG Jr, Keck PE Jr, McElroy SL. Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. Am J Psychiatry. 1986;143:1227–33.PubMed
21.
Zurück zum Zitat Adityanjee PA. The spectrum concept and prevalence of neuroleptic malignant syndrome. Am J Psychiatry. 1988;145(8):1041.PubMed Adityanjee PA. The spectrum concept and prevalence of neuroleptic malignant syndrome. Am J Psychiatry. 1988;145(8):1041.PubMed
Metadaten
Titel
Lethal neuroleptic malignant syndrome due to amisulpride
verfasst von
Frank Musshoff
Elke Doberentz
Burkhard Madea
Publikationsdatum
01.06.2013
Verlag
Springer US
Erschienen in
Forensic Science, Medicine and Pathology / Ausgabe 2/2013
Print ISSN: 1547-769X
Elektronische ISSN: 1556-2891
DOI
https://doi.org/10.1007/s12024-013-9410-1

Weitere Artikel der Ausgabe 2/2013

Forensic Science, Medicine and Pathology 2/2013 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …